These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 28959938

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB, Mendonça SC, Callahan H, Portal AC, Max G.
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro characterization of Leishmania (Viannia) braziliensis isolates from patients with different responses to Glucantime(®) treatment from Northwest Paraná, Brazil.
    Fernandes AC, Pedroso RB, de Mello TF, Donatti L, Venazzi EA, Demarchi IG, Aristides SM, Lonardoni MV, Silveira TG.
    Exp Parasitol; 2016 Aug; 167():83-93. PubMed ID: 27181585
    [Abstract] [Full Text] [Related]

  • 5. Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate.
    Perez-Franco JE, Cruz-Barrera ML, Robayo ML, Lopez MC, Daza CD, Bedoya A, Mariño ML, Saavedra CH, Echeverry MC.
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004739. PubMed ID: 27243811
    [Abstract] [Full Text] [Related]

  • 6. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
    Teva A, Porrozzi R, Oliveira-Neto MP, Grimaldi GJ.
    J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
    [Abstract] [Full Text] [Related]

  • 7. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA, de la Glória Orge Orge M, de Farias Guerra MV, Paes MG, de Oliveira Macêdo V, de Carvalho EM.
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients.
    Silva SC, Guimarães LH, Silva JA, Magalhães V, Medina L, Queiroz A, Machado PRL, Schriefer A.
    Acta Trop; 2018 Feb; 178():34-39. PubMed ID: 29042262
    [Abstract] [Full Text] [Related]

  • 15. Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil.
    Torres DC, Ribeiro-Alves M, Romero GA, Dávila AM, Cupolillo E.
    Acta Trop; 2013 May; 126(2):132-41. PubMed ID: 23416123
    [Abstract] [Full Text] [Related]

  • 16. Treatment of imported New World cutaneous leishmaniasis in Germany.
    Harms G, Scherbaum H, Reiter-Owona I, Stich A, Richter J.
    Int J Dermatol; 2011 Nov; 50(11):1336-1342. PubMed ID: 22004484
    [Abstract] [Full Text] [Related]

  • 17. Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
    de Morais-Teixeira E, Aguiar MG, Soares de Souza Lima B, Ferreira LA, Rabello A.
    J Antimicrob Chemother; 2015 Dec; 70(12):3283-90. PubMed ID: 26346991
    [Abstract] [Full Text] [Related]

  • 18. kDNA minicircle signatures of Leishmania (Viannia) braziliensis in oral and nasal mucosa from mucosal leishmaniasis patients.
    de Oliveira FS, Valete-Rosalino CM, Schubach Ade O, Pacheco Rda S.
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):361-5. PubMed ID: 20226327
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetic polymorphism in Leishmania (Viannia) braziliensis detected in mucosal leishmaniasis of HIV-infected and non-HIV-infected patients.
    de Oliveira FS, Valete-Rosalino CM, Schubach Ade O, Madeira Mde F, Pacheco Rda S.
    Trans R Soc Trop Med Hyg; 2012 Nov; 106(11):683-7. PubMed ID: 22954800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.